Skip to content

OnKure Therapeutics, Inc. OKUR Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.06M+246%
Replimune Group logo
Replimune GroupREPL
-$36K+92.9%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$3.03M-254%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.3M+454%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$708K+237%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
OnKure Therapeutics, Inc. (OKUR) reported increase (decrease) in prepaid expense and other assets of -$281K in Q1 2026.
How has OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets increased by 61.6% year-over-year, from -$731K to -$281K.
What is the long-term trend for OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 2 years (2021 to 2024), OnKure Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -30.8% compound annual growth rate (CAGR), from $4.71M to -$2.26M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.